TrialJCO precision oncology2025
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H.
Mohamed A Gouda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.